Company Filing History:
1 out of 4,443 
1 out of 344 
1 out of 207 Years Active: 1978-1983
Title: Claude H Nash, III: Innovator in Antibiotic Development
Introduction
Claude H Nash, III is a notable inventor based in Audubon, PA (US), recognized for his contributions to the field of antibiotic development. He holds a total of three patents, showcasing his innovative approach to creating novel antibiotic complexes.
Latest Patents
Nash's latest patents include significant advancements in anthracycline antibiotics produced by the microorganisms Streptosporangium fragile and Streptosporangium fragilis. The first patent describes a novel anthracycline antibiotic complex, known as the fragilomycin complex, which is produced by cultivating a fermentation broth containing Streptosporangium fragile Shearer sp. nov. ATCC 31519 in an aqueous nutrient medium under submerged aerobic conditions. This complex, along with its major bioactive component, fragilomycin A, exhibits notable antibiotic activity. Similarly, his second patent focuses on the fragilomycin complex derived from Streptosporangium fragilis Shearer, emphasizing its potential in antibiotic applications.
Career Highlights
Throughout his career, Nash has worked with prominent companies such as Eli Lilly and Company and SmithKline Corporation. His experience in these organizations has contributed to his expertise in antibiotic research and development.
Collaborations
Nash has collaborated with notable individuals in his field, including Marcia C Shearer and Kenneth M Snader. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
Claude H Nash, III stands out as an influential inventor in the realm of antibiotic development, with a focus on innovative solutions to combat bacterial infections. His work continues to impact the field significantly.